Indexed by Science Citation Index (SciSearch), International Pharmaceutical Abstract, Chemical Abstracts, Embase, Index Copernicus, EBSCO, African Index Medicus, JournalSeek, Journal Citation Reports/Science Edition, Directory of Open Access Journals (DOAJ), African Journal Online, Bioline International, Open-J-Gate

ISSN: 1596-5996 (print); 1596-9827 (electronic)-


Home | Back Issues | Current Issue | Review manuscript | Submit manuscript

 
 

This Article

 

Abstract

 

Full-text

 

Table of contents

 

Comments

 

Letters

 

Comments to Editor

 

e-mail Alert

 

Sign Up

 

 

Research Article


 

Determination of Letrozole in Tablet Formulations by Reversed Phase High Performance Liquid Chromatography

 

Mani Ganesh1,2*, Krishanan Rajasekar2, Margandan Bhagiyalakshmi1, Mari Vinoba3, Kavimani Saktimanigandan4, Hyun Tae Jang1

1Department of Chemical Engineering, Hanseo University, Season 360-706, South Korea, 2Department of  Nanotechnology, Biotechnology Centre, Anna University Coimbatore, Jothipuram, Coimbatore 641-047, India, 3Carbon Dioxide Reduction & Sequestration Research Center, Korea Institute of Energy Research, Deajon, 305-343, Korea, 4Alkem Lab Ltd, Taloja-410208, Navi Mumbai, Maharashtra, India

 

*Corresponding author:  E-mail: htjang@hanseo.ac.kr, chemgans@gmail.com, mbhagiya@gmail.com

Received: 17 April 2010                                                              Revised accepted: 30 August 2010

Tropical Journal of Pharmaceutical Research, October 2010; 9(5): 505-510

 

Abstract

 

Purpose: To develop a simple, rapid, accurate and cost-effective reversed phase high performance liquid chromatography (RP-HPLC) method for letrozole in bulk and in tablets.

Methods: Development of a method for the determination of letrozole, an anti-cancer drug, by RP-HPLC was undertaken using a new mobile phase of acetonitrile:water (50:50, v/v). The eluent was monitored at 265 nm.

Results: The optimized conditions developed showed a linear response from 160 to 240 µg/mL, with a correlation coefficient (R2) of 0.999. The limit of detection (LOD) and limit of quantification ( LOQ) were 136 and 160 µg/mL, respectively. The assay values for the two branded letrozole tablets tested were 99.2 and 100.2 %, respectively with % relative standard deviation (RSD) of 0.781 and 0.568, respectively. The bench top stability data of the drug in the mobile phase indicate that the drug was stable in the mobile phase for 24 h. Recovery data were good. Placebo study for specificity and interference of common excipients showed that the method was specific and free from interfering substances.

Conclusion: Therefore, the fully validated method developed was sensitive enough to carry out routine analysis of letrozole in tablet formulations with regard to its run time, simplicity of sample preparation and accuracy. 

 

Key words: Letrozole, Assay, HPLC, Validation, Tablet formulation.

Copyright@2002-2013. Pharmacotherapy Group, Faculty of Pharmacy, University of Benin, Benin City. All rights reserved.

Powered by Poracom E-mail: jmanager@poracom.net